NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/08/2019
Back to search
Official data from USPTO
ANASPEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ANASPEC
ST13
US500000076673709Class
1, 40, 42
Filing
76673709
Registration
3715584
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
03/08/2019
Classification
Registered
Trademark type
Word
Nice classes
1, 40, 42
Filing date
03/07/2007
Registration date
11/24/2009
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2019
Last transaction
03/08/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/2002
First use in commerce
01/01/2002
Drawing code
4
Owner type
03
Owner location
San Jose, CA, US
Examiner
HAMMEL, LAURA A
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
AnaSpec, Inc.
Representatives
Jeffrey A. McKinney McKinney Law Group APC
Technical classification
Nice Classes
Class 1Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biomedical compoundsmonoclonal antibodies used in analyzing and detecting certain enzymesreceptorsoligonucleotides and proteins for in vitro scientific laboratory or research use in the biotechnology and pharmaceutical industries; biomedical compounds in the nature of amino acidspeptides used in analyzing and detecting certain enzymesreceptorsoligonucleotides and proteins for laboratory or research use in the biotechnology and pharmaceutical industries; chemical reagents for non-medical purposes in the biotechnology and pharmaceutical industries
Class 40
Manufacture of peptides and antibodiessynthetic peptides for pharmaceutical purposes and monoclonal antibodies for in vitro scientific or research useto the specification of others for academic and industrial research
Class 42
Chemical and bio-chemical analysischemical laboratories and chemical research
Publications
History of USPTO decisions and trademark events.
50 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/08/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/08/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/08/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
02/04/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/24/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/19/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/19/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/19/2015
E815
TEAS SECTION 8 & 15 RECEIVED
08/18/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
10/22/2009
ALIE
ASSIGNED TO LIE
10/21/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/21/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/15/2009
IUAF
USE AMENDMENT FILED
09/11/2009
EISU
TEAS STATEMENT OF USE RECEIVED
09/11/2009
EX1G
SOU EXTENSION 1 GRANTED
08/06/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/05/2009
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
07/01/2009
PETG
PETITION TO REVIVE-GRANTED
07/01/2009
PROA
TEAS PETITION TO REVIVE RECEIVED
07/01/2009
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
06/22/2009
ABN6
ABANDONMENT - NO USE STATEMENT FILED
06/22/2009
EXT1
SOU EXTENSION 1 FILED
05/18/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/18/2008
PUBO
PUBLISHED FOR OPPOSITION
08/26/2008
NPUB
NOTICE OF PUBLICATION
08/06/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/24/2008
CNEA
EXAMINERS AMENDMENT MAILED
07/24/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
07/23/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/23/2008
CNRT
NON-FINAL ACTION MAILED
07/10/2008
CNRT
NON-FINAL ACTION WRITTEN
07/09/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2008
ALIE
ASSIGNED TO LIE
06/16/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2008
CNRT
NON-FINAL ACTION MAILED
01/15/2008
CNRT
NON-FINAL ACTION WRITTEN
01/14/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/17/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2007
CNRT
NON-FINAL ACTION MAILED
06/21/2007
CNRT
NON-FINAL ACTION WRITTEN
06/21/2007
DOCK
ASSIGNED TO EXAMINER
06/20/2007
MAFR
APPLICATION FILING RECEIPT MAILED
03/17/2007
NWAP
NEW APPLICATION ENTERED
03/13/2007
Continuous trademark protection
Get notified about every new filing that threatens ANASPEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.